Pracinostat | High-Quality Pharmaceutical Reference Standard
Pracinostat is a histone deacetylase (HDAC) inhibitor under investigation for the treatment of acute myeloid leukemia (AML) and other hematologic malignancies. It works by modulating gene expression, inducing cancer cell apoptosis and cell cycle arrest. Pracinostat API is produced under GMP standards and is suitable for oral solid dosage formulations.
Pracinostat API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 1
